Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px
Document › Details

Teva Pharmaceutical Industries Ltd.. (5/11/17). "Press Release: Teva Reports First Quarter 2017 Financial Results". Jerusalem.

Organisations Organisation Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)
  Group Teva (Group)
  Organisation 2 Actavis (Group) (new, since Jan 2013)
  Today Allergan (Group)
  Group Teva (Group)
Products Product pharmaceutical
  Product 2 DRUGS, GENERICS
  Index term 2 Allergan–Teva: investment, 201608 acquisition of Actavis generics business from Allergan plc for $33.43b in cash + 100m Teva shares
Person Person Peterburg, Yitzhak (Teva 201702– Interim CEO)
     


   
Record changed: 2017-05-15

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Teva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px